Ruti Aga's Six-Year Ban: How a Forged Prescription Ended an Elite Marathon Career
**मुख्य उत्तर:** रूटी अगा (इथियोपिया) को AIU ने छह साल का प्रतिबंध दिया, जो 10 सितंबर से लागू है। यह सज़ा दो साल (ग्लूकोकार्टिकॉइड उपस्थिति) और चार साल (नकली प्रिस्क्रिप्शन के ज़रिए छेड़छाड़) को जोड़कर बनी है। **मुख्य तथ्य:** - मिथाइलप्रेडनिसोलोन WADA सूची की S9 श्रेणी का ग्लूकोकार्टिकॉइड है, एनाबॉलिक स्टेरॉयड नहीं; यह केवल प्रतियोगिता के दौरान प्रतिबंधित है। - मार्च में चीन में जीती गई हाफ मैराथन के बाद अगा का सैंपल पॉज़िटिव पाया गया; उस दौड़ का समय सार्वजनिक नहीं किया गया। - प्रिस्क्रिप्शन उस क्लिनिक से बताया गया जो अस्तित्व में नहीं था; 'डॉक्टर' परिवार का सदस्य था जिसके पास मेडिकल रजिस्ट्रेशन नहीं था। - छह साल का प्रतिबंध अगा (32) को 2028 ओलंपिक चक्र से बाहर कर देता है; लौटने पर वे 38 की होंगी। - 2019 टोक्यो मैराथन खिताब और तीन वर्ल्ड मेजर में दूसरा स्थान उनके रिकॉर्ड में शामिल है। **स्रोत:** Athletics Integrity Unit (AIU) का बयान, 2026 में जारी | Cross-checked: cricsultan.com **संबंधित प्रश्न:** प्रश्न: क्या ग्लूकोकार्टिकॉइड इंजेक्शन प्रतिबंधित है? उत्तर: केवल प्रतियोगिता के दौरान और केवल तब जब सैंपल में अवशेष मिले; प्रतियोगिता से बाहर थेरेप्यूटिक उपयोग वैध है। प्रश्न: अगा की सज़ा छह साल क्यों है? उत्तर: दो साल उपस्थिति उल्लंघन और चार साल छेड़छाड़ (तम्परिंग) के लिए, जो कोड का मानक दंड है। प्रश्न: क्या उनके पुराने खिताब रद्द हुए? उत्तर: मार्च की उस चीनी दौड़ से पहले के परिणाम स्वतः रद्द नहीं होते; AIU सामान्यतः उसी प्रतियोगिता का परिणाम और प्राइज़ मनी रद्द करता है जहाँ सैंपल लिया गया।
Ruti Aga's name entered the Athletics Integrity Unit's doping control room after a half marathon she won in China in March, but the race produced no time, no split, no field-strength report made public. When the story of a 2:18-class marathoner begins not with her splits but with a forged prescription, it tells you the real contest is being fought on paper, not on the track. The six-year ban, effective from 10 September, removes the 32-year-old Aga entirely from the 2028 Olympic cycle.
This case departs from the doping narrative we are used to reading. The question here is not about steroids but about a glucocorticoid — and that technical detail is the centre of the entire case. Methylprednisolone, described in media reports as a 'prohibited steroid', is in fact a glucocorticoid under class S9 of the WADA Prohibited List, not an anabolic steroid (S1). Under the current List, S9 substances are prohibited in-competition only, and only by injection, oral or rectal routes. A therapeutic injection into the knee is entirely legal out of competition — it becomes a violation only if residues are present in a sample taken in competition.
One more fact matters here: the in-competition testing window for a road race opens at 23:59 the night before the race. An injection given days earlier can still be caught. Aga had a technical defence open to her — medical records, the date of the injection, a clear explanation of the route. What she did instead destroyed that one defence.

According to the AIU statement, Aga submitted a prescription citing a knee injury. Investigation found that the clinic said to have issued it did not exist. The 'doctor' was a family member with no medical registration, who claimed to have used 'an old prescription pad from a former workplace' — which the clinic explicitly disowned. Three independent verification failures. This is not a filing error but the signature of an athlete operating without a credentialed team physician.
The sanction arithmetic is straightforward: two years for the presence violation, and four years for tampering — six years in total, counted from the provisional suspension date of 10 September. That arithmetic tells us the panel rejected the no-significant-fault mitigation. The two-year presence sanction is consistent with the substance being a 'Specified' substance with intent not proven; the four years is the Code's standard tampering sanction.
The most interesting part of this case, to me, is that the reason for the ban is the paper, not the substance. A glucocorticoid has no proven benefit to endurance performance — it reduces pain and swelling, it does not make you faster. Aga received six years because she created false documents for a substance that offered no direct performance edge. That asymmetry is the real story.
Now the side that gets less attention. The 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors — that is the record of a genuinely elite marathoner. Results before that March race in China are not automatically annulled unless earlier use is proven. But under standard AIU practice, the result and prize money from the competition where the sample was collected are voided — and the report does not state that scope clearly.
Here is a counter-intuitive point that runs against the numbers. This six-year ban will be presented as a symbol of AIU rigour, but it can equally stand as an example of disproportionate enforcement against East African road runners. The medical support structure is thin, the TUE framework is near-absent, and label-race circuits like China's are a major income channel between Majors — the same circuit is now AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races.
Once more the same question: is the sanction proportionate to the offence, or is it punishing an individual for a systemic weakness? Aga is 32; returning after six years she would be 38, and within the depth of Ethiopian women's marathon there is no room for a 2:18-class returnee. In practical terms this is a lifetime ban. What does not change Ethiopia's medal arithmetic changes one athlete's entire life — and that may be the most honest figure in this case.
Next time you look at a road-race result, ask alongside the scoreboard which medical document and which prescription pad was circulating behind that race. Because in this sport, it is no longer the fastest runner who survives, but the one who keeps the cleanest paperwork.
